Piramal Pharma Limited has informed the Exchange about Annual Secretarial Compliance Report for the year ended 31st March, 2025
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma Limited has submitted its Annual Secretarial Compliance Report to the stock exchange for the financial year ended 31st March, 2025. This is a routine annual filing required by SEBI regulations (LODR), where the company's Practicing Company Secretary confirms whether the company has complied with all applicable SEBI rules, regulations, and stock exchange listing requirements during the year. The report covers the period from 1st April 2024 to 31st March 2025. No specific non-compliance issues or penalties have been highlighted in this announcement.
This is a routine regulatory disclosure with no direct impact on the stock price or shareholder value. Investors may want to review the full report on the stock exchange website to check for any reported deviations or observations regarding the company's compliance track record over the year.